Baotou Medical University Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Baotou China (1958)

Organization Overview

First Clinical Trial
2011
NCT01978730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Baotou Cancer Hospital | Baotou Central Hospital | Central Hospital of Baotou | the chief of of the neurology department, Central Hospital of Baotou | The First Affiliated Hospital of BaoTou Medical College | The Second Affiliated Hospital of Baotou Medical University

Active Ingredients

Drugs in Phase 4 Trials (3)

icotinib (Conmana) (1 trial)

octreotide (sandostatin) (1 trial)

terlipressin (Terlivaz) (1 trial)

Drugs in Phase 3 Trials (1)

capecitabine (xeloda) (1 trial)

Drugs in Phase 2 Trials (3)

Nelonemdaz (1 trial)

sailuotong (1 trial)

tenecteplase (tnkase) (1 trial)

Drugs in Other Trials (2)

gabapentin (neurontin) (1 trial)

pregabalin (lyrica) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 4)

Cerebral Infarction (Phase 2)

Dementia (Phase 2)

Dementia, Vascular (Phase 2)

Hemorrhage (Phase 4)

Infarction (Phase 2)

Ischemia (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 9